Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity
Jeremy R. Graff(United Therapeutics (United States)), Eric G. Marcusson(Ionis Pharmaceuticals (United States))
Cited by 377
Related Papers
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k